REACTing COVID-19

----- Ce site n’est plus mis à jour -----
Rendez-vous sur le site www.anrs.fr

Bienvenue sur la page Ressources. Sur cette page, vous aurez accès aux nouveautés et informations les plus récentes sur les outils, les possibilités de financement, les documents et les liens externes concernant les épidémies et le développement de la recherche entre les épidémies.

Filtrer par types

Publication International Journal of Environmental Research and Public Health March 2021 French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic

Schultz E., Ward J.K , Atlani-Duault L. , Holmes S.M. , Mancini J.

Source

Publication Lancet Public Health February 2021 Immune evasion means we need a new social contract

Atlani-Duault L, Lina B, Chauvin F, Delfraissy JF, Malvy D

Source

Publication PLOS One January 2021 Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France

Vanhems P, Gustin MP, Elias C, Henaff L, Dananché C, Grisi B, Marion E, Khanafer N, Hilliquin D, Gardes S, Gerbier-Colomban S, Amour S, Kuczewski E, Escuret V, Lina B, Saadatian-Elahi M; On behalf of COVID-Outcomes-HCL Consortium

Source

Publication Nature research December 2020 Underdetection of COVID-19 cases in France threatens epidemic control

Pullano G, Di Domenico L, Sabbatini CE, Valdano E, Turbelin C, Debin M, Guerrisi C, Kengne-Kuetche C, Souty C, Hanslik T, Blanchon T, Boëlle PY, Figoni J, Vaux S, Campèse C, Bernard-Stoecklin S, Colizza V

Source

Publication Lancet Public Health November 2020 COVID-19: France grapples with the Pragmatics of Isolation

Atlani-Duault L, Lina B, Malvy D, Yazdanpanah Y, Chauvin F, Delfraissy JF

Source

Publication The Lancet October 2020 Evaluating the effect of demographic factors, socioeconomic factors, and risk aversion on mobility during the COVID-19 epidemic in France under lockdown: a population-based study

Giulia Pullano, Eugenio Valdano, Nicola Scarpa, Stefania Rubrichi, Vittoria Colizza

Source

Publication Journal of Antimicrobial Chemotherapy October 2020 Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

Lê MP, Peiffer-Smadja N, Guedj J, et al.

Source

Publication BMJ Open October 2020 Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project

Saadatian-Elahi M, Picot V, Hénaff L, Pradel FK, Escuret V, Dananché C, Elias C, Endtz HP, Vanhems P

Source

Publication Emerging Infectious Diseases September 2020 Prolonged Infectivity of SARS-CoV-2 in Fomites

Pastorino B, Touret F, Gilles M, de Lamballerie X, Charrel RN

Source

Publication Nature Medecine September 2020 COVID-19 clinical trials: learning from exceptions in the research chaos

Tikkinen, K.A.O., Malekzadeh, R., Schlegel, M. et al.

Source

Publication BMJ Open September 2020 Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults

Ader F, Discovery French Trial Management Team

Source

Publication Science Translational Medicine September 2020 A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S

Source